News | April 01, 2021
Promoters of Lincoln Pharma increases holding by 4.9%
The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020
The promoter holding in the company has increased to 37.25%, a rise of 4.9% from 32.35% as of 31 March 2020
_256_384.jpg)
The company expects to generate an EBITDA margin before special items of around 27 percent in 2021.
Be One is a 100% Ayurvedic health and wellness supplement.
Subscribe To Our Newsletter & Stay Updated
